29 janvier 2027
FDA PDUFA target action date for ulixacaltamide, a NDA from Praxis Precision Medicines. This is the date by which the FDA is due to act on the application; it can be extended or the decision can come earlier.
Calendrier Dates de décision PDUFA de la FDA